FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2186-2191

  Wang, Gongchao ^a   Liu, Guangying ^a   Liu, Ying ^a   Li, Xiaona ^a   Su, Zhenhui ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal cancer; FOXP3; Prognosis

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84866442606     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11961     Document Type: Article

References (13)

1. Herszenyi L, Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14940:249-258.
2. Hurmuzlu M, Ovrebo KK, Monge OR, et al.: High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2010; 8:46.
3. Beyer M, Schultze JL: Regulatory T cells in cancer. Blood 2006; 108:804-811.
4. Fontenot JD, Rasmussen JP, Williams LM, et al.: Regulatory T cell lineage specification by the fork head transcription factor foxp3. Immunity 2005; 22:329-341.
5. Brunkow ME, Jeffery EW, Hjerrild KA, et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
6. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
7. Michel S, Benner A, Tariverdian M, et al.: High density of FOXP3-positive T cells infiltrating colorectal cancer with microsatellite instability. Brit J Cancer 2008; 99:1867-1873.
8. Wang GC, Zhang N, Liu GY: The expression and significance of CD4+ CD25+ regulatory T cells in esophageal carcinoma. Shandong Med J 2010; 50:80-81.
9. Roncador G, Brown PJ, Maestre L, et al.: Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immune 2005; 35:1681-1691.
10. Zhang XZ, Zhao XJ, Wang LH: Esophageal cancer. M. Peking: Peking University Medical Publishing Company; 2006:62-84.
11. Kobayashi N, Hiraoka N, Yamagami W, et al.: FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007; 13:902-911.
12. Siddiqui SA, Frigola X, Bonne-Annee S, et al.: Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007; 13:2075-2081.
13. Yoshioka T, Miyamoto M, Cho Y, et al.: infiltrating regulatory T cell numbers is not a factor to predict patient's survival in esophageal squamous cell carcinoma. Brit J Cancer 2008; 98:1258-1263.